1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C VirusNYANGUILE, Origène; DEVOGELAERE, Benoit; VANDERCRUYSSEN, Geneviève et al.Journal of virology. 2010, Vol 84, Num 6, pp 2923-2934, issn 0022-538X, 12 p.Article

Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patientsAMADO, Rafael G; MITSUYASU, Ronald T; MACPHERSON, Janet L et al.Human gene therapy. 2004, Vol 15, Num 3, pp 251-262, issn 1043-0342, 12 p.Article

TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic CoverageDEVOGELAERE, Benoit; BERKE, Jan Martin; LENZ, Oliver et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 9, pp 4676-4684, issn 0066-4804, 9 p.Article

Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosisPANTELIDIS, Panagiotis; FANNING, Gregory C; WELLS, Athol U et al.American journal of respiratory and critical care medicine. 2001, Vol 163, Num 6, pp 1432-1436, issn 1073-449XArticle

Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the Hepatitis C Virus NS5B PolymeraseMARTIN BERKE, Jan; VIJGEN, Leen; VAN DEN EYNDE, Christel et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 8, pp 3812-3820, issn 0066-4804, 9 p.Article

In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435LENZ, Oliver; VERBINNEN, Thierry; VERMEIREN, Katrien et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 5, pp 1878-1887, issn 0066-4804, 10 p.Article